HRP-conjugated anti-Dxd mAb

HRP-conjugated anti-Dxd mAb

Background

Dxd (Exatecan derivative for ADC) is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a

conjugated drug of HER2-targeting ADC (DS-8201a). Dxd is cytotoxic to human cancer cell lines of KPL-4,

NCI-N87, SK-BR-3, and MDA-MB-468 with IC50s of 1.43 nM-4.07 nM, HRP-anti-DXD-antibody is a

conjugation product of HRP and anti-DXD-antibody. It can be used in PK, PD analysis and ELISA.

Immunogen: Dxd-KLH

Specificity: Specifically recognizes the target-DXD

Source: Mouse, Monoclonal Clone #13

Isotype: IgG1

Conjugate: HRP (Horseradish Peroxidase) Conjugated

Concentration: 1.0mg/ml

Tested applications: ELISA

Recommended dilution: 1:1000 - 1:5000(optimal dilutions should be determined by the end use.)

Storage Buffer: PBS Buffer, pH7.4

Storage: Store at 2°C to 8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Stable for 2

years from date of receipt. Aliquot to avoid repeated freezing and thawing.

* Please note: FOR RESEARCH USE ONLY